These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33011351)

  • 1. Food dyes as P-glycoprotein modulators.
    Staples JW; Stine JM; Mäki-Lohiluoma E; Steed E; George KM; Thompson CM; Woodahl EL
    Food Chem Toxicol; 2020 Dec; 146():111785. PubMed ID: 33011351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of xanthene food dyes by inhibition of human drug-metabolizing enzymes in a noncompetitive manner.
    Mizutani T
    J Environ Public Health; 2009; 2009():953952. PubMed ID: 20041016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Kampo medicines on P-glycoprotein.
    Satoh T; Watanabe Y; Ikarashi N; Ito K; Sugiyama K
    Biol Pharm Bull; 2009 Dec; 32(12):2018-21. PubMed ID: 19952421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.
    Bansal T; Jaggi M; Khar RK; Talegaonkar S
    J Pharm Pharm Sci; 2009; 12(1):46-78. PubMed ID: 19470292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L; Eagling VA; Back DJ
    AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.
    Orlowski S; Mir LM; Belehradek J; Garrigos M
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):515-22. PubMed ID: 8713080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
    Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI
    Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
    Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
    Elsby R; Surry DD; Smith VN; Gray AJ
    Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
    Dahan A; Sabit H; Amidon GL
    AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
    Shukla S; Robey RW; Bates SE; Ambudkar SV
    Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function.
    Parasrampuria DA; Lantz MV; Benet LZ
    Pharm Res; 2001 Jan; 18(1):39-44. PubMed ID: 11336351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel non-natural nucleoside that influences P-glycoprotein activity and mediates drug resistance.
    Eng KT; Berdis AJ
    Biochemistry; 2010 Mar; 49(8):1640-8. PubMed ID: 20104904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfiram metabolites permanently inactivate the human multidrug resistance P-glycoprotein.
    Loo TW; Bartlett MC; Clarke DM
    Mol Pharm; 2004; 1(6):426-33. PubMed ID: 16028354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures.
    Hirsch-Ernst KI; Ziemann C; Rustenbeck I; Kahl GF
    Toxicology; 2001 Oct; 167(1):47-57. PubMed ID: 11557129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
    Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of synthetic and natural food dyes on activities of CYP2A6, UGT1A6, and UGT2B7.
    Kuno N; Mizutani T
    J Toxicol Environ Health A; 2005 Aug; 68(16):1431-44. PubMed ID: 16009655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical interaction of anti-HCV telaprevir with the ABC transporters P-glycoprotein and breast cancer resistance protein.
    Fujita Y; Noguchi K; Suzuki T; Katayama K; Sugimoto Y
    BMC Res Notes; 2013 Nov; 6():445. PubMed ID: 24196382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
    Garrigos M; Mir LM; Orlowski S
    Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.